UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Latest from UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Investigational RNA Interference Therapy, ARO-HIF2, Yields Encouraging Phase 1 Results in Clear Cell RCC
May 12, 2022
Article
Patients with clear cell renal cell carcinoma experienced reduced levels of hypoxia inducible factor-2 alpha expression following treatment with ARO-HIF2.